Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings

NARecruitingINTERVENTIONAL
Enrollment

650

Participants

Timeline

Start Date

August 5, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Uterine Cervical Neoplasms
Interventions
DIAGNOSTIC_TEST

Self-sampled HPV DNA testing

Participants will be offered HPV DNA testing done through self-sampling (using self-sampling HPV DNA kits to obtain a mid-vaginal swab)

DIAGNOSTIC_TEST

Clinician-sampled HPV DNA test

Participants will be offered HPV DNA testing through clinician sampling (clinician-sampling (speculum examination by a nurse to obtain a cervical swab)

Trial Locations (1)

138543

RECRUITING

National Healthcare Group Polyclinics, Singapore

Sponsors
All Listed Sponsors
collaborator

National Healthcare Group, Singapore

OTHER_GOV

collaborator

KK Women's and Children's Hospital

OTHER_GOV

lead

National Healthcare Group Polyclinics

OTHER_GOV

NCT06528184 - Evaluating the Impact of Different Methods of HPV DNA Testing for Cervical Cancer Screening in Primary Care Settings | Biotech Hunter | Biotech Hunter